Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Alex Anteau | February 27, 2024
"There's no thornier issue than obviousness in patentability," said IP attorney Kevin Crosby.
5 minute read
By Jim Soong | February 26, 2024
Each decision involves reversal of a prior art rejection and contrasts with the other decisions on subject matter eligibility, revealing different PTAB approaches and results that can inform prosecution and appeal strategies.
10 minute read
By Leanne Rakers and Caley McCarthy | February 21, 2024
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.
8 minute read
By Amanda O'Brien | February 16, 2024
Duke Fitch started at the company as a medicinal chemist and rose to vice president of U.S. pharmaceutical patents after earning his law degree.
2 minute read
By Ed Lanquist, Jr. and Dominic Rota | February 15, 2024
At what point does a "smart" computing system, or advanced software program, qualify as AI in the eyes of pertinent regulatory or judicial authorities? When is an individual considered to have merely deployed an AI-based computing tool to assist with creating a work of art or conceiving of a technological innovation? Each of these questions is explored in this article, giving consideration to currently prevailing guidelines from administrative bodies and the courts.
11 minute read
By Justin Henry | January 31, 2024
David Sharrow, based in Boston, held a leadership role in Gunderson's strategic transactions and licensing group for over a decade.
4 minute read
By Alex Anteau | January 30, 2024
The most common rationale for the dearth of patent filings has been "the economy," however, the report also notes jurisdictional changes may be a cause.
5 minute read
By Alex Anteau | January 24, 2024
If user inputs are used to train models such as ChatGPT, can lawyers input their clients confidential information when generating motions, briefs or patent applications? How does scraped data used to train AI co-exist with the right to be forgotten? And when it comes to filing patents and copyrights for works produced by AI, who owns it?
4 minute read
By Charles F. Wieland III and Sean M. Douglass | January 24, 2024
AI has been used in a number of ways to contribute to the development of an invention and such AI inventions can be categorized as follows: inventions that embody an advance in the field of AI itself; inventions that apply AI; and inventions produced by AI itself.
8 minute read
By Mark Liang. Paige Hardy and Grace McFee | January 16, 2024
Part One of a Two-Part Article Under the current Alice framework, those attempting to patent AI innovations face an uphill battle. But, as the caselaw demonstrates, inventors and patent drafters can take steps to reduce the risk of AI patent claims being invalidated as abstract ideas.
18 minute read
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS